Health ❯Healthcare ❯Neurology

Alzheimer's Disease

Cognitive Decline Mild Cognitive Impairment Lecanemab Biomarkers Disease Progression Treatment Options Risk Factors Vaccine Impact Monoclonal Antibodies Diagnostic Tests Cognitive Function Restoration Early Diagnosis Sleep Disorders Therapies Occupational Health Cognitive Decline Prediction Differential Diagnosis Model Development Drug Impact Prediction Models

Biogen Reports Mixed Q4 Results and Lowers 2025 Outlook

Potential Blood Test for Early Alzheimer’s Diagnosis Shows Promising Results

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

Researchers Confirm Human Brain's Waste-Clearing Pathways

Scottish Researchers Leverage AI to Predict Dementia Risk Using 1.6 Million Brain Scans

UCLA Researchers Develop Molecule That Restores Memory in Alzheimer's Model Mice

GLP-1 Drug Shows Promise in Slowing Alzheimer's Cognitive Decline

EU Regulator Denies Approval for Alzheimer's Drug Lecanemab

Shingles Vaccine Linked to Reduced Dementia Risk

AI Advances Enhance Early Alzheimer's Detection and Prognosis